Moxie, a clinical-grade operating system designed for aesthetic medicine practices, announced it has raised $25 million in Series C funding. The round was led by Viewpoint Ventures, with participation from SignalFire, Lachy Groom, and Haystack.
The new capital brings Moxie’s total funding to $51 million and will support the company’s mission to bring operational infrastructure to independent aesthetic medicine practices.
Alongside the funding announcement, the company introduced Scale Suite, a new product offering designed to provide multi-provider operational infrastructure, margin intelligence, and AI-driven compliance tools for aesthetic practices.
Founded to address operational challenges faced by clinicians running aesthetic practices, Moxie provides an integrated platform combining software, coaching, and compliance infrastructure tailored specifically for the aesthetics industry. The company supports more than 700 practices across the United States.
The company said the aesthetic medicine sector has expanded rapidly in recent years, with the U.S. medical aesthetics market estimated at $18 billion in 2025 and the number of medspas increasing from fewer than 5,000 in 2010 to more than 15,000 nationwide. However, many clinicians entering the space lack formal business training, leaving them responsible for managing finances, operations, compliance, and hiring without the support infrastructure available to large chains or private equity-backed groups.
Moxie was founded around what it describes as a “clinically-led growth” approach, which emphasizes strong clinical standards supported by operational discipline, financial transparency, and regulatory compliance.
According to the company, practices using its platform grow 60% faster than the industry average and achieve 10% higher margins while saving more than $5,000 per month on products and supplies. The company reports a 97% customer retention rate, with more than 20% of new practices joining through referrals.
The newly launched Scale Suite expands the company’s platform with tools designed to help independent practices operate and scale more effectively.
- Practice 360 assessments that analyze more than 300 operational and financial data points across practice workflows and performance metrics.
- Multi-provider practice management tools integrated into Moxie’s EMR platform, including scheduling, payroll, and operational controls tailored to aesthetic medicine workflows.
- Moxie Capital, which provides financing paired with a proprietary decision framework to guide practice investments.
- Recruiting support for clinical and operational roles to help practices expand their teams.
- Maia, an AI-powered practice assistant designed to support compliance monitoring, inventory management, and patient inquiries.
- Margin intelligence tools that provide financial reporting, service-level profitability analysis, pricing guidance, and compensation modeling.
- Compliance and regulatory safeguards, including automated alerts and audit-ready documentation.
- Clinical Business Mastery, an education program and playbook library developed with an advisory board of physicians, injectors, and operators in aesthetic medicine.
Moxie said the Series C funding will be used to accelerate development of the Scale Suite platform, expand its clinical education and advisory programs, grow its Scale Society community of aesthetic practice owners, and invest in engineering and operational teams to support a growing customer base.
KEY QUOTES:
“The aesthetic practices that thrive long-term aren’t the loudest or the busiest. They’re the most disciplined. We built Moxie to give independent practice owners the same caliber of operating infrastructure that was previously only available to those backed by institutional capital. Moxie’s Scale Suite is the next step in that mission, making it possible for every ambitious practice owner to grow with structure, financial clarity, and peace of mind.”
Kamau Massey, Chief Executive Officer of Moxie
“I went into aesthetic medicine because I love patient care, not because I wanted to spend my nights reconciling spreadsheets and doing workarounds in an EMR that wasn’t built for this specialty. Moxie let me stop being a firefighter and start being a CEO. The financial clarity alone changed how I make decisions. But what changed my practice most was having a team behind me that actually understands how aesthetic businesses operate — not just how software works. Moxie has helped me gain control over my business so my business doesn’t have control over me.”
Natalie Uden, MSN, FNP-C, Founder and CEO of Oro Valley Aesthetics
“Aesthetic medicine has grown faster than its infrastructure. We have world-class clinicians running practices on spreadsheets and workarounds — and that’s a risk to patients, to margins, and to the long-term credibility of the specialty. I joined Moxie’s Aesthetic Business Advisory Board because they’re the only company I’ve seen that treats this problem with the seriousness it deserves. Clinically-led growth isn’t a marketing phrase. It’s the operating discipline that separates practices that scale from practices that collapse under their own weight.”
Dr. David Saadat, Founder and CEO of The Beverly Hills Aesthetic Surgical Institute
